PRESS RELEASE published on 12/05/2024 at 09:30, 1 year 8 months ago Eckert & Ziegler and Ariceum Therapeutics Sign Global Supply Agreement for the Development of Next-Generation Radiotherapeutics for Precision Cancer Treatments Eckert & Ziegler and Ariceum Therapeutics sign global supply agreement for developing next-generation radiotherapeutics. Collaboration to accelerate targeted cancer treatments Eckert & Ziegler Ariceum Therapeutics Global Supply Agreement Radiotherapeutics Precision Cancer Treatments
BRIEF published on 12/03/2024 at 14:34, 1 year 8 months ago Eckert & Ziegler Announces Executive and Supervisory Board Changes Executive Board Supervisory Board Eckert & Ziegler Dr. Gunnar Mann Jutta Ludwig
BRIEF published on 12/03/2024 at 14:34, 1 year 8 months ago Eckert & Ziegler annonce des changements au sein de son conseil d'administration et de son conseil de surveillance Eckert & Ziegler Conseil De Surveillance Conseil Exécutif Jutta Ludwig Dr Gunnar Mann
PRESS RELEASE published on 12/03/2024 at 14:29, 1 year 8 months ago Eckert & Ziegler: Changes in the Executive Board and Supervisory Board Eckert & Ziegler SE appoints Dr. Gunnar Mann to Executive Board and welcomes changes in Supervisory Board. Dr. Mann to lead Medical segment Executive Board Supervisory Board Eckert & Ziegler SE Medical Segment Dr. Gunnar Mann
BRIEF published on 12/02/2024 at 09:05, 1 year 8 months ago Eckert & Ziegler Initiates Actinium-225 Production to Tackle Global Shortage Nuclear Medicine Radiopharmaceuticals Actinium-225 Production Isotope Supply GMP Certification
BRIEF published on 12/02/2024 at 09:05, 1 year 8 months ago Eckert & Ziegler lance la production d'actinium 225 pour faire face à la pénurie mondiale Produits Radiopharmaceutiques Médecine Nucléaire Production D'actinium 225 Approvisionnement En Isotopes Certification GMP
PRESS RELEASE published on 12/02/2024 at 09:00, 1 year 8 months ago Eckert & Ziegler Begins Production of Actinium-225, Paving the Way for GMP-Grade Supply Eckert & Ziegler starts Actinium-225 production in collaboration with Czech Academy of Sciences, aiming for GMP-grade supply to boost alpha-emitting radiopharmaceuticals development Eckert & Ziegler Production Radiopharmaceuticals Actinium-225 GMP-grade
BRIEF published on 11/27/2024 at 09:05, 1 year 8 months ago Eckert & Ziegler Gains European Approval for Theralugand® Cancer Therapy Radiopharmaceuticals Lutetium-177 European Approval Theralugand®
BRIEF published on 11/27/2024 at 09:05, 1 year 8 months ago Eckert & Ziegler obtient l'approbation européenne pour Theralugand® Produits Radiopharmaceutiques Thérapie Contre Le Cancer Lutetium-177 Theralugand® Agrément Européen
PRESS RELEASE published on 11/27/2024 at 09:00, 1 year 8 months ago Eckert & Ziegler Achieves European Approval for Theralugand® - Lutetium-177 Chloride (n.c.a) Eckert & Ziegler receives EC approval for Theralugand® - Lutetium-177 Chloride, expanding cancer therapy options in Europe Eckert & Ziegler Cancer Therapy EC Approval Theralugand Lutetium-177 Chloride
Published on 08/10/2026 at 08:00, 2 hours 10 minutes ago Galantas Gold Expands Indiana Drill Program to 12,500 Metres
Published on 08/10/2026 at 08:00, 2 hours 10 minutes ago Results of AGM and Management Update Presentation
Published on 08/07/2026 at 23:15, 2 days 10 hours ago Faraday Copper Reports Second Quarter 2026 Financial Results
Published on 08/07/2026 at 23:00, 2 days 11 hours ago Rio Grande Resources Announces up to $2,500,000 Non-Brokered Private Placement Financing
Published on 08/10/2026 at 09:50, 20 minutes ago Photon Energy N.V. Bond 21/27 (ISIN: DE000A3KWKY4): Signs of a crisis are mounting. What can investors do? Invitation to video conferences (German/English)
Published on 08/10/2026 at 09:00, 1 hour 10 minutes ago Original-Research: Rosenbauer International AG (von NuWays AG): BUY
Published on 08/10/2026 at 09:00, 1 hour 10 minutes ago Original-Research: Bittium Oyj (von NuWays AG): BUY
Published on 08/10/2026 at 09:00, 1 hour 10 minutes ago Synnovis milestone: 2,000 revolutionary blood tests for NHS lung and breast cancer patients
Published on 08/10/2026 at 09:22, 48 minutes ago Number of shares and voting rights - July 2026 (In French only)
Published on 08/10/2026 at 09:22, 48 minutes ago Nombre total d'actions et droits de vote - juillet 2026
Published on 08/10/2026 at 07:00, 3 hours 10 minutes ago BIOPHYTIS ANNOUNCES APPROVAL OF THE OBA CLINICAL TRIAL IN BRAZIL AND SHARES ITS OUTLOOK FOR BIO101 IN OBESITY
Published on 08/10/2026 at 07:00, 3 hours 10 minutes ago Biophytis annonce l’autorisation de l’étude clinique OBA au Brésil et partage les perspectives de BIO101 dans l’obésité
